Consult with some of the most authoritative names in pharmacy. Head for the Exhibit Hall where pharmacy experts are stationed at tables, each labeled with their area of expertise. Choose an expert in an area important to you and ask your burning questions.

• Table 1: Pharmacy Law and Liability Issues
  Kenneth R. Baker, BS Pharm, JD, Of Counsel/ Pharmacy Consultant, Renaud Cook Drury Mesaros, PA, Phoenix, AZ


• Table 2: Developing Support Protocols for IV Robotics
  Luci Power, BS, MS, Senior Pharmacy Consultant, Power Enterprises, San Francisco, CA


• Table 3: Innovative Roles for Pharmacy Technicians
  Angela T. Cassano, PharmD, BCPS, President, Pharmfusion Consulting, LLC, Midlothian, VA


• Table 4: Glucose Control in the Hospital Setting
  Paul Szumita, PharmD, BCPS, Clinical Pharmacy Practice Manager, Brigham and Women s Hospital, Boston, MA; and Adjunct Assistant Professor of Pharmacy Critical Care, Northeastern University, Boston, MA


• Table 5: Preparing for a Joint Commission (or Other Accrediting Organization's) Survey
  John P. (Pat) Uselton, RPh, BS, Vice President, Quality and Regulatory, Cardinal Health, Houston, TX; Lee B. Murdaugh, RPh, PhD, Director, Accreditation and Medication Safety, Cardinal Health, Houston, TX; and Patricia C. Kienle, BSc Pharm, MPA, FASHP, Director, Accreditation and Medication Safety, Cardinal Health, Houston, TX


• Table 6: Infectious Diseases and Antimicrobial Stewardship
  Curtis D. Collins, PharmD, MS, Clinical Pharmacist, Infectious Diseases, University of Michigan Health System, Ann Arbor


• Table 7: The Potential Impact of the American Recovery and Reinvestment Act (ARRA) on Pharmacy Practice
  Kevin A. Scheckelhoff, BS Pharm, MBA, Vice President, Medication Safety Solutions, McKesson Corporation, San Francisco, CA


• Table 8: The Joint Commission: Meeting the Standards
  Jeannell M. Mansur, BSc, PharmD, Practice Leader, Medication Safety, Joint Commission Resources, Oakbrook Terrace, IL


• Table 9: Pharmacogenomics: Bridging the Gap between Science and Practice
  Grace M. Kuo, PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine, University of California, San Diego, La Jolla and Joseph D. Ma, PharmD, Assistant Professor, University of California, San Diego, Skaggs School of Pharmacy & Pharmaceutical Sciences, San Diego


• Table 10: Antithrombotic Drug Use in the Cardiac Cath Lab
  Carl Peterson, PharmD, Clinical Director, Cardiovascular Diseases, Cardinal Health, Houston, TX


• Table 11: Geriatric Pharmacy Practice
  Jeannie Kim Lee, PharmD, BCPS, Clinical Assistant Professor, University of Arizona College of Pharmacy, Tucson; and Geriatric Pharmacy Specialist, Southern Arizona VA Health Care System, Tucson


• Table 12: Key Findings from the 2009 ASHP National Survey
  Craig A. Pedersen, PhD, FAPhA, Consultant, Craig A. Pedersen Consulting, Mercer Island, WA


• Table 13: Enhancing Patient Comfort with Effective Sedation
  Lois F. Parker, BS, RPh, Senior Attending Pharmacist, PICU; and Pediatric Pharmacy Team Lead, Massachusetts General Hospital, Boston.


• Table 14: Current Topics in Diabetes Management
  Pamela L. Stamm, PharmD, BCPS, Associate Professor of Pharmacy Practice, Auburn University, Auburn, AL; and Clinical Pharmacy Specialist, Central Alabama Veteran s Health Care System, Columbus, GA


• Table 15: 2009-10 Political/Policy Landscape; Health Care Reform & Advocacy
  Brian M. Meyer, MBA, Director, Government Affairs Division, American Society of Health-System Pharmacists, Bethesda, MD; and Joseph Hill, MA, Director, Federal Legislative Affairs, American Society of Health-System Pharmacists, Bethesda, MD


• Table 16: Health and Human Services Agenda; Medicaid and Technicians
  Justine Coffey, JD, LLM, Director, Federal Regulatory Affairs, American Society of Health-System Pharmacists, Bethesda, MD; and Geralyn Trujillo, MPP, Director, State Government Affairs, American Society of Health-System Pharmacists, Bethesda, MD


• Table 17: Integrating CPOE and ADMs into the Medication Management Process
  Deborah A. Wible, PharmD, Chief Pharmacy Officer, Continuum Health Partners, New York, NY


• Table 18: Optimizing Antidote Stocking
  Daniel Cobaugh, PharmD, FAACT, Senior Director for Research and Operations, ASHP Research and Education Foundation, Bethesda, MD; and Richard C. Dart, MD, PhD, Director, Rocky Mountain Poison and Drug Center, Denver, CO


• Table 19: Inpatient Anticoagulation Standardization and Care Provision
  Michael P. Gulseth, PharmD, BCPS, Program Director for Anticoagulation Services, Sanford USD Medical Center, Department of Pharmaceutical Services, Sioux Falls, SD


• Table 20: Getting Your Work Published in Pharmacy Journals and Careers in Academic Pharmacy
  Terry L. Schwinghammer, PharmD, BCPS, FASHP, Professor and Chair, Department of Clinical Pharmacy, West Virginia University, Morgantown; Edward L. Decker, PharmD, Clinical Manager of Pharmacy, Tufts Medical Center, Boston, MA; and Lea S. Eiland, PharmD, BCPS, Associate Clinical Professor of Pharmacy Practice, Auburn University Harrison School of Pharmacy, Auburn, AL


• Table 21: Neonatal Pharmacotherapy
  Christopher C. McPherson, PharmD, Clinical Pharmacist, Neonatal ICU, St. Louis Children s Hospital, St. Louis, MO


• Table 22: Preventing Medication Errors in Cancer Chemotherapy
  James M. Hoffman, PharmD, MS, Medication Outcomes and Safety Officer, St. Jude Children s Research Hospital; and Assistant Professor of Clinical Pharmacy, University of Tennessee Health Science Center, Memphis; Robert DeChristoforo, MS, FASHP, Chief Pharmacist, National Institutes of Health Clinical Center, Bethesda, MD; and Barry Goldspiel, PharmD, FASHP, Projects Coordinator Pharmacist, National Institutes of Health Clinical Center, Bethesda, MD


• Table 23: Clinical Informatics
  John Poikonen, PharmD, Clinical Informatics Director, UMass Memorial Medical Center, Worcester, MA


• Table 24: 340B and Patient Safety / Clinical Pharmacy Services
  Christopher A. Hatwig, MS, RPh, FASHP, Vice President, 340B Prime Vendor Program/Apexus, Irving, TX; Jimmy R. Mitchell, RPh, MPH, Director, Office of Pharmacy Affairs, Health Resources and Services Administration, U.S. Department of Health and Human Services, Rockville, MD; Krista Pedley, PharmD, MS, Improvement Advisor, Office of Pharmacy Affairs, Health Resources and Services Administration, U.S. Department of Health and Human Services, Rockville, MD; and Lisa M. Scholz, PharmD, MBA, Senior Director, Health Resources and Services Administration Pharmacy Services Support Center (managed by APhA), Washington, D.C.


• Table 25: Submitting Medical Service Claims for Pharmacists Clinical Activities
  Daniel E. Buffington, PharmD, MBA, President and CEO, Clinical Pharmacology Services, Inc., Tampa, FL


• Table 26: Serum Creatinine Assay Standardization
  Leigh Ann Milburn, PharmD, BCPS, System P & T Committee Pharmacist, Saint Luke s Health System, Kansas City, MO


• Table 27: Pharmacy Roles in Disaster Response
  CDR Michael P. Bourg, PharmD, Chief Pharmacy Officer, Office of Preparedness and Emergency Operations, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, D.C.; and Lee Joffee, PharmD, Team Leader, National Pharmacy Logistics Team, Logistics, Office of Preparedness and Emergency Operations, U.S. Department of Health and Human Services, Yorktown Heights, NY


• Table 28: Optimizing Automation and Technology: Pharmacy to Bedside Charting
  Brian Mansfield, RPH, MHA, RXinnovate Consulting, Bethany, CT